Roivant Sciences Ltd.

NasdaqGS:ROIV 株式レポート

時価総額:US$8.4b

Roivant Sciences マネジメント

マネジメント 基準チェック /44

Roivant Sciencesの CEO はMatt Glineで、 Jan2021年に任命され、 の在任期間は 3.83年です。 の年間総報酬は$ 738.19Kで、 98.2%給与と1.8%のボーナス(会社の株式とオプションを含む)で構成されています。 は、会社の株式の0.002%を直接所有しており、その価値は$ 203.25K 。経営陣と取締役会の平均在任期間はそれぞれ3.8年と3.2年です。

主要情報

Matt Gline

最高経営責任者

US$738.2k

報酬総額

CEO給与比率98.2%
CEO在任期間3.8yrs
CEOの所有権0.002%
経営陣の平均在職期間3.8yrs
取締役会の平均在任期間3.2yrs

経営陣の近況

Recent updates

Roivant Sciences: Good Value, But Near-Term Catalysts Could Bring Volatility

Oct 22

Statutory Earnings May Not Be The Best Way To Understand Roivant Sciences' (NASDAQ:ROIV) True Position

Aug 22
Statutory Earnings May Not Be The Best Way To Understand Roivant Sciences' (NASDAQ:ROIV) True Position

Roivant Sciences: Inherently Risky Business Model, But Track Record Impresses

Aug 22

Roivant Sciences: Executing On Huge Buyback Program With More To Come

Jun 02

Roivant Sciences: $7bn Televant Sale Sets It Up For Long-Term Success

Mar 18

We Believe Roivant Sciences' (NASDAQ:ROIV) Earnings Are A Poor Guide For Its Profitability

Feb 21
We Believe Roivant Sciences' (NASDAQ:ROIV) Earnings Are A Poor Guide For Its Profitability

These Analysts Just Made A Decent Downgrade To Their Roivant Sciences Ltd. (NASDAQ:ROIV) EPS Forecasts

Nov 15
These Analysts Just Made A Decent Downgrade To Their Roivant Sciences Ltd. (NASDAQ:ROIV) EPS Forecasts

Are Investors Undervaluing Roivant Sciences Ltd. (NASDAQ:ROIV) By 21%?

Apr 26
Are Investors Undervaluing Roivant Sciences Ltd. (NASDAQ:ROIV) By 21%?

Broker Revenue Forecasts For Roivant Sciences Ltd. (NASDAQ:ROIV) Are Surging Higher

Nov 22
Broker Revenue Forecasts For Roivant Sciences Ltd. (NASDAQ:ROIV) Are Surging Higher

Newsflash: Roivant Sciences Ltd. (NASDAQ:ROIV) Analysts Have Been Trimming Their Revenue Forecasts

Sep 29
Newsflash: Roivant Sciences Ltd. (NASDAQ:ROIV) Analysts Have Been Trimming Their Revenue Forecasts

CEO報酬分析

Roivant Sciences の収益と比較して、Matt Gline の報酬はどのように変化したか?
日付総報酬給与会社業績
Sep 30 2024n/an/a

US$5b

Jun 30 2024n/an/a

US$5b

Mar 31 2024US$738kUS$725k

US$4b

Dec 31 2023n/an/a

US$5b

Sep 30 2023n/an/a

-US$927m

Jun 30 2023n/an/a

-US$1b

Mar 31 2023US$49mUS$725k

-US$1b

Dec 31 2022n/an/a

-US$1b

Sep 30 2022n/an/a

-US$1b

Jun 30 2022n/an/a

-US$1b

Mar 31 2022US$30mUS$725k

-US$845m

Dec 31 2021n/an/a

-US$1b

Sep 30 2021n/an/a

-US$1b

Jun 30 2021n/an/a

-US$888m

Mar 31 2021US$8mUS$350k

-US$809m

報酬と市場: Mattの 総報酬 ($USD 738.19K ) は、 US市場 ($USD 7.94M ) の同様の規模の企業の平均を下回っています。

報酬と収益: Mattの報酬は、過去 1 年間の会社の業績と一致しています。


CEO(最高経営責任者

Matt Gline (40 yo)

3.8yrs

在職期間

US$738,189

報酬

Mr. Matthew Gline, also known as Matt, is Chief Executive Officer of Roivant Sciences Ltd. since January 26, 2021 and its Director since September 30, 2021. He has been Chief Executive Officer of Roivant S...


リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Matthew Gline
CEO & Director3.8yrsUS$738.19k0.0024%
$ 203.2k
Mayukh Sukhatme
President3.8yrsUS$574.56k0.50%
$ 42.0m
Richard Pulik
Chief Financial Officer3.2yrsUS$5.15m0.020%
$ 1.7m
Rakhi Kumar
Chief Accounting Officer6.3yrsUS$4.33m0.016%
$ 1.3m
Eric Venker
President & COO6yrsUS$48.49m0.038%
$ 3.2m
Drew Kramer
Chief Information Officerno dataデータなしデータなし
Josh Chen
General Counselno dataデータなしデータなし
Kelly Graff
Head of People2.8yrsデータなしデータなし
Alex Gasner
Executive Vice President of Roivant Healthno dataデータなしデータなし
Matt Maisak
Chief Operating Officer of Roivant Platformsno dataデータなしデータなし
Srini Ramanathan
Chief Development Officer2.5yrsデータなしデータなし
David Rubenstein
Chief Scientific Officer of Dermavantno dataデータなしデータなし

3.8yrs

平均在職期間

44yo

平均年齢

経験豊富な経営陣: ROIVの経営陣は 経験豊富 であると考えられます ( 3.8年の平均在職年数)。


取締役

名称ポジション在職期間報酬所有権
Matthew Gline
CEO & Director3.2yrsUS$738.19k0.0024%
$ 203.2k
Mayukh Sukhatme
Presidentless than a yearUS$574.56k0.50%
$ 42.0m
Meghan FitzGerald
Independent Director1.7yrsUS$941.68k0.0018%
$ 148.9k
Keith Manchester
Independent Director10.8yrsUS$442.59k0.17%
$ 14.5m
James Momtazee
Independent Director3.2yrsUS$459.24k0.011%
$ 887.4k
Daniel Gold
Independent Director4.8yrsUS$449.24k0.88%
$ 73.9m
Melissa Epperly
Independent Director2.4yrsUS$444.24k0.0030%
$ 248.4k
Ilan Oren
Independent Chairman10.8yrsUS$488.49k0.011%
$ 935.9k

3.2yrs

平均在職期間

50yo

平均年齢

経験豊富なボード: ROIVの 取締役会経験豊富 であると考えられます ( 3.2年の平均在任期間)。